Satoru Sumitani
Kitamura, 5510032, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.
Journal: Cardiovascular diabetology
Published: March 27, 2023
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: May 21, 2021
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial.
Journal: Cardiovascular diabetology
Published: October 06, 2020
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
Journal: Cardiovascular diabetology
Published: April 06, 2020
Neuropsychiatric Immune-related Adverse Events Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma and Systemic Lupus Erythematosus.
Journal: Internal medicine (Tokyo, Japan)
Published: November 01, 2019
Two cases with Hb Andrew-Minneapolis showing high or low-normal HbA1c levels depending on the measurement method.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: October 02, 2018
A case of monoclonal gammopathy of undetermined significance with abnormal low levels of plasma glycated albumin by M protein.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: April 13, 2018
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: July 20, 2017
Metformin decreases glycated albumin to glycated haemoglobin ratio in patients with newly diagnosed type 2 diabetes.
Journal: Annals of clinical biochemistry
Published: March 08, 2014
Effectiveness of metformin and lifestyle interventions as an initial treatment in Japanese patients with newly diagnosed type 2 diabetes: a prospective observational study.
Journal: The journal of medical investigation : JMI
Published: March 28, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026